Sale!

Prostate Health Index PHI Test

660 د.إ

-10%

The Prostate Health Index (PHI) Test is an innovative and highly specific tool for assessing the health of the prostate and aiding in the early detection of prostate cancer. Unlike traditional screening methods that solely rely on Prostate-Specific Antigen (PSA) levels, the PHI Test combines the results of three different PSA markers – total PSA, free PSA, and [-2]proPSA. By calculating these markers into a single score, the PHI Test provides a more accurate indication of the likelihood of prostate cancer, especially in detecting more aggressive forms of the disease.

This advanced diagnostic approach is crucial for men, particularly those with a family history of prostate cancer or those who have had previous elevated PSA levels, as it helps in making more informed decisions regarding the necessity of a biopsy. Early detection through the PHI Test can significantly enhance treatment outcomes and potentially reduce the need for invasive procedures.

The Prostate Health Index Test is available at DNA Labs UAE, a leading facility known for its commitment to providing cutting-edge medical testing services. The cost of the PHI Test at DNA Labs UAE is 660 AED. Opting for this test at DNA Labs UAE ensures not only accuracy but also confidentiality and support from specialized medical professionals, making it a valuable resource for men concerned about their prostate health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PROSTATE HEALTH INDEX PHI Test

The Prostate Health Index (PHI) test is a blood test used to assess the risk of prostate cancer in men. It combines the results of three different prostate-specific antigen (PSA) tests to provide a more accurate evaluation of the likelihood of having prostate cancer.

Test Details

The PHI test measures three types of PSA in the blood: total PSA, free PSA, and proPSA. By analyzing the ratio of these three PSA forms, the PHI test can help differentiate between prostate cancer and benign conditions, such as an enlarged prostate or inflammation.

The PHI test is typically recommended for men with elevated PSA levels (between 4 and 10 ng/mL) and a negative digital rectal examination (DRE). It can provide additional information to guide further diagnostic procedures, such as a prostate biopsy, or to monitor the progression of prostate cancer in men with a confirmed diagnosis.

Compared to the traditional PSA test, the PHI test has shown improved specificity and accuracy in identifying aggressive prostate cancer, while reducing unnecessary biopsies for men with benign conditions. However, it is important to note that the PHI test is not a definitive diagnostic tool and should be used in conjunction with other clinical evaluations.

Test Name: PROSTATE HEALTH INDEX PHI Test

Components:

  • PSA, Total
  • PSA, Free
  • P2PSA

Price: 660.0 AED

Sample Condition:

2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Do not draw sample within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography.

Report Delivery:

Sample Mon / Thu by 4 pm; Report Same day

Method: CMIA, CLIA

Test type: Prostate Cancer

Doctor: Oncologist

Test Department: THYROID & HORMONES

Pre Test Information:

Do not give sample within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography.

It is recommended to consult with a healthcare professional to determine if the PHI test is appropriate for individual circumstances and to interpret the results accurately.

Test Name PROSTATE HEALTH INDEX PHI Test
Components *PSA,Total*PSA,Free*P2PSA
Price 660.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Shiprefrigeratedorfrozen.Donotdraw samplewithin7daysofDigitalRectal Examination (DRE) or Rectal Prostatic Ultrasonography.
Report Delivery SampleMon / Thu by 4 pm; Report Same day
Method CMIA, CLIA
Test type Prostate Cancer
Doctor Oncologist
Test Department: THYROID & HORMONES
Pre Test Information Donot give samplewithin7daysofDigitalRectal Examination (DRE) or Rectal Prostatic Ultrasonography.
Test Details

The Prostate Health Index (PHI) test is a blood test used to assess the risk of prostate cancer in men. It combines the results of three different prostate-specific antigen (PSA) tests to provide a more accurate evaluation of the likelihood of having prostate cancer.

The PHI test measures three types of PSA in the blood: total PSA, free PSA, and proPSA. By analyzing the ratio of these three PSA forms, the PHI test can help differentiate between prostate cancer and benign conditions, such as an enlarged prostate or inflammation.

The PHI test is typically recommended for men with elevated PSA levels (between 4 and 10 ng/mL) and a negative digital rectal examination (DRE). It can provide additional information to guide further diagnostic procedures, such as a prostate biopsy, or to monitor the progression of prostate cancer in men with a confirmed diagnosis.

Compared to the traditional PSA test, the PHI test has shown improved specificity and accuracy in identifying aggressive prostate cancer, while reducing unnecessary biopsies for men with benign conditions. However, it is important to note that the PHI test is not a definitive diagnostic tool and should be used in conjunction with other clinical evaluations.

It is recommended to consult with a healthcare professional to determine if the PHI test is appropriate for individual circumstances and to interpret the results accurately.